company background image
RHK logo

RHÖN-KLINIKUM XTRA:RHK Stock Report

Last Price

€10.90

Market Cap

€729.6m

7D

-2.7%

1Y

-17.4%

Updated

18 Apr, 2024

Data

Company Financials

RHÖN-KLINIKUM Aktiengesellschaft

XTRA:RHK Stock Report

Market Cap: €729.6m

RHK Stock Overview

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany.

RHK fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends2/6

RHÖN-KLINIKUM Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RHÖN-KLINIKUM
Historical stock prices
Current Share Price€10.90
52 Week High€13.70
52 Week Low€9.50
Beta-0.029
1 Month Change-1.80%
3 Month Change7.92%
1 Year Change-17.42%
3 Year Change-30.40%
5 Year Change-58.16%
Change since IPO321.79%

Recent News & Updates

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Mar 02
RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Dec 19
Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Recent updates

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Mar 02
RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Dec 19
Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

Jul 13
Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

Jun 15
There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Aug 11
Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Apr 01
Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

May 14
Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

Shareholder Returns

RHKDE HealthcareDE Market
7D-2.7%4.1%-1.5%
1Y-17.4%-0.8%0.9%

Return vs Industry: RHK underperformed the German Healthcare industry which returned -3.8% over the past year.

Return vs Market: RHK underperformed the German Market which returned -0.4% over the past year.

Price Volatility

Is RHK's price volatile compared to industry and market?
RHK volatility
RHK Average Weekly Movement5.9%
Healthcare Industry Average Movement5.6%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.0%
10% least volatile stocks in DE Market2.4%

Stable Share Price: RHK has not had significant price volatility in the past 3 months.

Volatility Over Time: RHK's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197314,132Tobias Kaltenbachwww.rhoen-klinikum-ag.com

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary

How do RHÖN-KLINIKUM's earnings and revenue compare to its market cap?
RHK fundamental statistics
Market cap€729.63m
Earnings (TTM)€38.71m
Revenue (TTM)€1.73b

18.8x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHK income statement (TTM)
Revenue€1.73b
Cost of Revenue€1.53b
Gross Profit€202.88m
Other Expenses€164.16m
Earnings€38.71m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 08, 2024

Earnings per share (EPS)0.58
Gross Margin11.69%
Net Profit Margin2.23%
Debt/Equity Ratio11.1%

How did RHK perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.